Resting heart rate and the risk of type 2 diabetes: a systematic review and doseeresponse meta-analysis of cohort studies
Author(s)
Aune, D
Hartaigh, BO
Vatten, LJ
Type
Journal Article
Abstract
Background
High resting heart rate has been associated with increased risk of type 2 diabetes in several studies, but the available data are not consistent and it is unclear if there is a dose–response relationship between resting heart rate and type 2 diabetes risk. We aimed to clarify this association by conducting a systematic review and meta-analysis of published studies.
Methods and results
PubMed, Embase and Ovid Medline databases were searched for prospective studies published up until October 11th, 2013. Summary relative risks were estimated using a random effects model. Ten cohort studies with >5628 cases and 119,915 participants were included. The summary RR for high vs. low resting heart rate was 1.83 (95% CI: 1.28–2.60, I2 = 88%, n = 7), and in the dose–response analysis the summary RR was 1.20 (95% CI: 1.07–1.34, I2 = 93%, n = 9) for an increase of 10 beats per minute. The heterogeneity was to a large degree explained by two studies. There was evidence of nonlinear associations between resting heart rate (pnonlinearity < 0.0001) and risk of type 2 diabetes.
Conclusion
The current meta-analysis indicates a strong positive association between high resting heart rate and the risk of type 2 diabetes. As a non-invasive marker of type 2 diabetes risk, resting heart rate may have potential in the clinical setting, especially for interventions aimed at lowering the risk of type 2 diabetes. Additional studies are needed to clarify the mechanisms that may be responsible for the assoiation between resting heart rate and type 2 diabetes.
High resting heart rate has been associated with increased risk of type 2 diabetes in several studies, but the available data are not consistent and it is unclear if there is a dose–response relationship between resting heart rate and type 2 diabetes risk. We aimed to clarify this association by conducting a systematic review and meta-analysis of published studies.
Methods and results
PubMed, Embase and Ovid Medline databases were searched for prospective studies published up until October 11th, 2013. Summary relative risks were estimated using a random effects model. Ten cohort studies with >5628 cases and 119,915 participants were included. The summary RR for high vs. low resting heart rate was 1.83 (95% CI: 1.28–2.60, I2 = 88%, n = 7), and in the dose–response analysis the summary RR was 1.20 (95% CI: 1.07–1.34, I2 = 93%, n = 9) for an increase of 10 beats per minute. The heterogeneity was to a large degree explained by two studies. There was evidence of nonlinear associations between resting heart rate (pnonlinearity < 0.0001) and risk of type 2 diabetes.
Conclusion
The current meta-analysis indicates a strong positive association between high resting heart rate and the risk of type 2 diabetes. As a non-invasive marker of type 2 diabetes risk, resting heart rate may have potential in the clinical setting, especially for interventions aimed at lowering the risk of type 2 diabetes. Additional studies are needed to clarify the mechanisms that may be responsible for the assoiation between resting heart rate and type 2 diabetes.
Date Issued
2015-02-27
Date Acceptance
2015-02-19
Citation
Nutrition Metabolism and Cardiovascular Diseases, 2015, 25 (6), pp.526-534
ISSN
1590-3729
Publisher
Elsevier
Start Page
526
End Page
534
Journal / Book Title
Nutrition Metabolism and Cardiovascular Diseases
Volume
25
Issue
6
Copyright Statement
© 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Endocrinology & Metabolism
Nutrition & Dietetics
Cardiovascular System & Cardiology
Resting heart rate
Type 2 diabetes
Systematic review
Meta-analysis
SYMPATHETIC-NERVOUS-SYSTEM
INDUCED INSULIN-RESISTANCE
MIDDLE-AGED MEN
RANDOMIZED-TRIAL
CARDIOVASCULAR MORBIDITY
HYPERTENSIVE PATIENTS
AUTONOMIC FUNCTION
BLOOD-PRESSURE
MELLITUS
DISEASE
Diabetes Mellitus, Type 2
Heart Rate
Humans
Nonlinear Dynamics
Predictive Value of Tests
Prognosis
Rest
Risk Assessment
Risk Factors
Cardiovascular System & Hematology
11 Medical And Health Sciences
Publication Status
Published